All times are listed in CET (Central European Time)
Multidisciplinary Tumour Board
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Room
Channel 1
Chairs
- F. Cappuzzo (Rome, NY, Italy)
- L. Landi (Ravenna, Italy)
Optimal management of patients with PDL1-high advanced NSCLC
Multidisciplinary Tumour Board
Presentation of case: Monotherapy or chemoimmunotherapy in PD-L1>50%?
Lecture Time
11:15 - 11:20
Speakers
- L. Landi (Ravenna, Italy)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
- L. Landi (Ravenna, Italy)
Optimal management of patients with PDL1-high advanced NSCLC
Multidisciplinary Tumour Board
Options in patients with brain metastases
Lecture Time
11:20 - 11:35
Speakers
- O. Gautschi (Luzern, Switzerland)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
- O. Gautschi (Luzern, Switzerland)
Optimal management of patients with PDL1-high advanced NSCLC
Multidisciplinary Tumour Board
Role of chemo-free combinations
Lecture Time
11:35 - 11:50
Speakers
- S. Ramalingam (Atlanta, GA, United States of America)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
- S. Ramalingam (Atlanta, GA, United States of America)
Optimal management of patients with PDL1-high advanced NSCLC
Multidisciplinary Tumour Board
Role of chemo-IO combinations
Lecture Time
11:50 - 12:05
Speakers
- F. Cappuzzo (Rome, NY, Italy)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
- F. Cappuzzo (Rome, NY, Italy)
Optimal management of patients with PDL1-high advanced NSCLC
Multidisciplinary Tumour Board
Role of single agent immunotherapy
Lecture Time
12:05 - 12:20
Speakers
- M. Garcia Campelo (A Coruña, Spain)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
- M. Garcia Campelo (A Coruña, Spain)
Optimal management of patients with PDL1-high advanced NSCLC
Multidisciplinary Tumour Board
Q&A and live discussion
Lecture Time
12:20 - 12:35
Speakers
- A. Speakers (, Switzerland)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
- A. Speakers (, Switzerland)